To test if maternal hemodynamics, and bioimpedance, together with the Combined Screening (maternal history, biophysical and biochemical markers), are able to identify normotensive non-obese patients at risk for preeclampsia (PE) and/or intrauterine growth restriction (IUGR) in the first trimester of gestation.
Gagliardi, G., Tiralongo, G., Lo Presti, D., Pisani, I., Farsetti, D., Vasapollo, B., et al. (2017). Screening for preeclampsia in the first trimester: role of maternal hemodynamics and bioimpedence in non obese patients. ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 50(5), 584-588 [10.1002/uog.17379].
Screening for preeclampsia in the first trimester: role of maternal hemodynamics and bioimpedence in non obese patients
Farsetti, D;Vasapollo, B;ANDREOLI, ANGELA;VALENSISE, HERBERT CARMELO CARLO
2017-01-01
Abstract
To test if maternal hemodynamics, and bioimpedance, together with the Combined Screening (maternal history, biophysical and biochemical markers), are able to identify normotensive non-obese patients at risk for preeclampsia (PE) and/or intrauterine growth restriction (IUGR) in the first trimester of gestation.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
